Insulin resistance and metformin in polycystic ovary syndrome

被引:45
作者
Ben-Haroush, A [1 ]
Yogev, Y
Fisch, B
机构
[1] Rabin Med Ctr, Dept Obstet & Gynecol, Infertil & IVF Unit, IL-49100 Petah Tiqwa, Israel
[2] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel
关键词
metformin; polycystic ovary syndrome; insulin resistance;
D O I
10.1016/j.ejogrb.2003.11.027
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Polycystic ovary syndrome (PCOS) is a heterogeneous disorder with widespread systemic manifestations affecting 5-10% of women of reproductive age. The accompanying insulin resistance and hypeinsulinemia mark this syndrome as a prediabetic state, with high incidence of impaired glucose tolerance, gestational diabetes, and overt diabetes. Other metabolic and biochemical changes, such as hypertension and dyslipidemia, increase the risk of cardiovascular disease. Fertility may also be impaired due to anovulation, impaired implantation, and higher rates of spontaneous abortions. All of these effects may also be related to hyperinsulinemia. Metformin, as insulin- sensitizing drug, is being evaluated for its potential long-term disease-modifying effect, such as prevention of diabetes. Its use may also help restore spontaneous ovulation and improve menstrual cyclicity, improve the success rate of induction of ovulation with clomiphene citrate and FSH, and decrease the high rate of ovarian hyperstimulation and early pregnancy loss. Nevertheless, these new exiting potential benefits of metformin should be evaluated in large randomized controlled studies, and clinicians must counsel women appropriately before the initiation of metformin therapy. (C) 2004 Published by Elsevier Ireland Ltd.
引用
收藏
页码:125 / 133
页数:9
相关论文
共 87 条
[1]   Results of a placebo-controlled study of the metabolic effects of the addition of metaformin to sulfonylurea-treated patients - Evidence for a central role of adipose tissue [J].
Abbasi, F ;
Kamath, V ;
Rizvi, AA ;
Carantoni, M ;
Chen, YDI ;
Reaven, GM .
DIABETES CARE, 1997, 20 (12) :1863-1869
[2]   PREVALENCE OF POLYCYSTIC OVARIES IN WOMEN WITH ANOVULATION AND IDIOPATHIC HIRSUTISM [J].
ADAMS, J ;
POLSON, DW ;
FRANKS, S .
BRITISH MEDICAL JOURNAL, 1986, 293 (6543) :355-359
[3]  
*AM COLL OBST GYN, 2002, PRACT B, V41
[4]   Polycystic ovaries in women with gestational diabetes [J].
Anttila, L ;
Karjala, K ;
Penttilä, TA ;
Ruutiainen, K ;
Ekblad, U .
OBSTETRICS AND GYNECOLOGY, 1998, 92 (01) :13-16
[5]   Thiazolidinediones but not metformin directly inhibit the steroidogenic enzymes P450c17 and 3β-hydroxysteroid dehydrogenase [J].
Arlt, W ;
Auchus, RJ ;
Miller, WL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (20) :16767-16771
[6]   Metformin directly inhibits androgen production in human thecal cells [J].
Attia, GR ;
Rainey, WE ;
Carr, BR .
FERTILITY AND STERILITY, 2001, 76 (03) :517-524
[7]   METFORMIN - AN UPDATE [J].
BAILEY, CJ .
GENERAL PHARMACOLOGY, 1993, 24 (06) :1299-1309
[8]   Metformin for the treatment of polycystic ovary syndrome [J].
Barbieri, RL .
OBSTETRICS AND GYNECOLOGY, 2003, 101 (04) :785-793
[9]   INSULIN STIMULATES ANDROGEN ACCUMULATION IN INCUBATIONS OF OVARIAN STROMA OBTAINED FROM WOMEN WITH HYPERANDROGENISM [J].
BARBIERI, RL ;
MAKRIS, A ;
RANDALL, RW ;
DANIELS, G ;
KISTNER, RW ;
RYAN, KJ .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1986, 62 (05) :904-910
[10]   Induction of ovulation in infertile women with hyperandrogenism and insulin resistance [J].
Barbieri, RL .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2000, 183 (06) :1412-1418